Sign up to save your podcasts
Or
Share Recently Approved Drugs: Pembrolizumab for cHL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
More shows like ASCO Education
View all
JAMA Editors' Summary
139 Listeners
Economist Podcasts
4,235 Listeners
NEJM This Week
322 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
TED Health
1,438 Listeners
JAMA Clinical Reviews
507 Listeners
Hidden Brain
43,883 Listeners
ASCO Daily News
61 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
285 Listeners
Mayo Clinic Talks
282 Listeners
The Curbsiders Internal Medicine Podcast
3,338 Listeners
The Daily
111,156 Listeners
The ONS Podcast
195 Listeners
ASCO Guidelines
45 Listeners
Two Onc Docs
181 Listeners